RWS
LGND icon

Retirement Wealth Solutions’s Ligand Pharmaceuticals LGND Stock Holding History

Retirement Wealth Solutions’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.64K Hold
21
– – ﹤0.01% 292
2026
Q1 		$4.19K Sell
21
-36
-63% -$7.12K ﹤0.01% 354
2025
Q4 		$10.8K Hold
57
– – 0.01% 219
2025
Q3 		$10.1K Sell
57
-15
-21% -$2.23K 0.01% 225
2025
Q2 		$8.19K Hold
72
– – 0.01% 255
2025
Q1 		$7.57K Hold
72
– – 0.01% 257
2024
Q4 		$7.65K Buy
+72
New +$8.14K 0.01% 256

Other funds holding LGND

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
PWG
Portside Wealth Group Provo, Utah $858M AUM 26.82% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Retirement Wealth Solutions's LGND Position: Q2 2026 in Review

Retirement Wealth Solutions held its Ligand Pharmaceuticals (LGND) position steady in Q2 2026 at 21 shares worth $6.64K. The position accounts for ﹤0.01% of the portfolio, ranked #292.

Retirement Wealth Solutions first reported a position in LGND in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.8K in Q4 2025. 36 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Retirement Wealth Solutions held 21 shares of Ligand Pharmaceuticals worth $6.64K as of Q2 2026.
  • Retirement Wealth Solutions left its Ligand Pharmaceuticals share count unchanged in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Retirement Wealth Solutions's portfolio in Q2 2026, its #292 holding.
  • Retirement Wealth Solutions first reported a position in Ligand Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Retirement Wealth Solutions's Ligand Pharmaceuticals position peaked at $10.8K in Q4 2025.
  • 36 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Retirement Wealth Solutions's 13F filing for Q2 2026, filed 7 Jul 2026.